Dec. 17, 2022

Robin Mansukhani - CEO of Deciduous Therapeutics - Immunotherapy

In this episode of the Life Science Success Podcast my guest is Robin Mansukhani.  Robin is the CEO of Deciduous Therapeutics, a venture backed startup developing novel immunotherapies to treat age-related diseases. Additionally, he co-founded...


In this episode of the Life Science Success Podcast my guest is Robin Mansukhani.  Robin is the CEO of Deciduous Therapeutics, a venture backed startup developing novel immunotherapies to treat age-related diseases. Additionally, he co-founded BlueStamp Engineering, an intensive, project-based engineering program for high school students in NYC, San Francisco, and Palo Alto.

Introduction

 

02:00 Tell listeners about yourself

03:33 Whenever you were in venture capital, did it help you at all in terms of looking for companies like Des Deciduous whenever you were examining companies?

04:41 Because you have that experience, does it help you as well to find funding for the companies you work with?

09:00 What made you want to come away from venture capital into, more of the medical device and also, now Phar pharmaceutical?

10:20 What led to the company's creation and to your being there? 

11:00 The name Des Deciduous you mentioned, what it is, but where did it come from?

13:55 What do you expect the outcome will be and then, where are you guys at currently?

16:00 And then in terms of blue Stamp Engineering whenever I read about this I was very interested to hear, more about, what made you start it and then what specifically is it doing as well.

22:16 And then the things that they primarily focus on though would be anything that has to do with engineering as a whole? Or is there, are there specific focus areas that Blue Stamp focuses then on?

26:14 There are three questions that I like to ask every guest.

          -What Inspires you?

27:55 -What concerns you? 

30:08 -What excites you?

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.  

robin mansukhaniProfile Photo

robin mansukhani

CEO

Robin Mansukhani is the CEO and Co-Founder of Deciduous Therapeutics, a venture-backed start-up developing novel immunotherapies to treat age related diseases. He also been an advisor to several early stage biotech companies in the Aging and CNS space including Therini Bio and Reservoir Neurosciences. Previously, Robin co-founded and served as President and CEO of Alzeca Biosciences, a diagnostic imaging company for CNS disorders, which is supported by venture investors, the Alzheimer's Drug Discovery Foundation, and an NIH Direct to Phase 2 Grant. Robin has been an invited keynote speaker both domestically and abroad, including TEDx. Previously, Mr. Mansukhani worked in early stage venture capital at The Maple Fund and investment banking at Axiom Capital. He has also co-founded BlueStamp Engineering, an intensive, project-based engineering program for high school students. Robin previously served a term in AmeriCorps where he led health and literacy programs. Mr. Mansukhani holds a B.S. in Biochemistry from Case Western Reserve University.